IL6 and atherosclerosis: diHPA exerted anti-inflammatory properties by reducing the secretion of pro-inflammatory cytokines, TNF-α, IL-1β and IL-6, involved in the early stages of atherosclerosis from lipopolysaccharide (LPS)-stimulated human peripheral blood mononuclear cells (PBMC).